DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Hadden RD, Marreno F.
Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction.
Ther Adv Neurol Disord 2015;
8: 14-19
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.